TX SB403 | 2023-2024 | 88th Legislature
Status
Spectrum: Partisan Bill (Republican 17-0)
Status: Engrossed on April 27 2023 - 50% progression, died in chamber
Action: 2023-05-23 - Committee report sent to Calendars
Text: Latest bill text (Comm Sub) [HTML]
Status: Engrossed on April 27 2023 - 50% progression, died in chamber
Action: 2023-05-23 - Committee report sent to Calendars
Text: Latest bill text (Comm Sub) [HTML]
Summary
Relating to a study on the adverse reactions and efficacy of COVID-19 vaccines.
Title
Relating to a study on the adverse reactions and efficacy of COVID-19 vaccines.
Sponsors
Roll Calls
2023-04-27 - Senate - Read 3rd time (Y: 31 N: 0 NV: 0 Abs: 0) [PASS]
2023-04-27 - Senate - Three day rule suspended (Y: 31 N: 0 NV: 0 Abs: 0) [PASS]
2023-04-27 - Senate - Three day rule suspended (Y: 31 N: 0 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2023-05-23 | House | Committee report sent to Calendars |
2023-05-22 | House | Committee report distributed |
2023-05-22 | House | Comte report filed with Committee Coordinator |
2023-05-18 | House | Reported favorably w/o amendment(s) |
2023-05-18 | House | Considered in formal meeting |
2023-04-28 | House | Referred to Public Health |
2023-04-28 | House | Read first time |
2023-04-27 | House | Received from the Senate |
2023-04-27 | Senate | Reported engrossed |
2023-04-27 | Senate | Record vote |
2023-04-27 | Senate | Passed |
2023-04-27 | Senate | Read 3rd time |
2023-04-27 | Senate | Record vote |
2023-04-27 | Senate | Three day rule suspended |
2023-04-27 | Senate | Vote recorded in Journal |
2023-04-27 | Senate | Read 2nd time & passed to engrossment |
2023-04-27 | Senate | Laid before the Senate |
2023-04-27 | Senate | Placed on local & uncontested calendar |
2023-04-19 | Senate | Committee report printed and distributed |
2023-04-19 | Senate | Recommended for local & uncontested calendar |
2023-04-19 | Senate | Reported favorably as substituted |
2023-04-17 | Senate | Vote taken in committee |
2023-04-17 | Senate | Considered in public hearing |
2023-03-27 | Senate | Co-author authorized |
2023-03-22 | Senate | Left pending in committee |
2023-03-22 | Senate | Testimony taken in committee |
2023-03-22 | Senate | Considered in public hearing |
2023-03-22 | Senate | Scheduled for public hearing on . . . |
2023-02-15 | Senate | Referred to Health & Human Services |
2023-02-15 | Senate | Read first time |
2023-01-12 | Senate | Filed |
2023-01-12 | Senate | Received by the Secretary of the Senate |
Same As/Similar To
HB1313 (Similar To) 2023-03-20 - Left pending in committee
HB1313 (Similar To) 2023-03-20 - Left pending in committee
HB1313 (Similar To) 2023-03-20 - Left pending in committee
Subjects
COVID-19
Health
HEALTH & HUMAN SERVICES COMMISSION
Health--General
Health--Other Diseases & Medical Conditions
IMMUNIZATIONS
Interim Studies
STATE HEALTH SERVICES, DEPARTMENT OF
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
Health
HEALTH & HUMAN SERVICES COMMISSION
Health--General
Health--Other Diseases & Medical Conditions
IMMUNIZATIONS
Interim Studies
STATE HEALTH SERVICES, DEPARTMENT OF
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON